✦ LIBER ✦

A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease

✍ Scribed by Tomohiro Onishi; Hiroki Iwashita; Yumiko Uno; Jun Kunitomo; Morihisa Saitoh; Eiji Kimura; Hisashi Fujita; Noriko Uchiyama; Masakuni Kori; Masayuki Takizawa

Book ID: 111184721
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 731 KB
Volume: 119
Category: Article
ISSN: 0022-3042
DOI: 10.1111/j.1471-4159.2011.07532.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of (S)-2-((S)-2-(3,5-Difluorop

Discovery of (S)-2-((S)-2-(3,5-Difluorophenyl)-2-hydroxyacetamido)-N-( (S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d] [1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-Secretase Inhibitor with Aβ Lowering Activity in a Transgenic Mouse Model of Alzheimer′s Disease.

✍ C. V. C. Prasad; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views